Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Psychiatric-Mental Health Certification Study Guide, Study notes of Nursing

This comprehensive study guide covers key topics in psychiatric and mental health nursing, including brain anatomy, neurotransmitters, mental disorders, nursing theories, defense mechanisms, personality disorders, and pharmacological treatments. It provides detailed information on the brain's lobes, neurotransmitters, heritability of mental disorders, nurse-patient relationship, and levels of prevention. The guide also discusses personality disorders, electroconvulsive therapy, cognitive function disturbances, and withdrawal symptoms, as well as commonly prescribed psychotropic medications.

Typology: Study notes

2023/2024

Available from 09/27/2024

tizian-mwangi
tizian-mwangi 🇺🇸

3.5

(4)

1.7K documents

1 / 14

Toggle sidebar

Related documents


Partial preview of the text

Download Psychiatric-Mental Health Certification Study Guide and more Study notes Nursing in PDF only on Docsity! 1 / Study Guide for Psychiatric - Mental Health Certification/latest /must have/24/25 1.Brain Anatomy: Frontal Lobe, Temporal Lobe, Parietal Lobe, Occipital Lobe. 2.Frontal Lobe: *Higher level executive or cognitive functioning - Decision making, planning, organizing, impulse control. *Working memory *Personality 3.Temporal Lobe: *Important for hearing, interpret spoken language, learning and memory, and emotional responses. *Receptive aphasia - Inability to interpret spoken language; failure to receive input as speaker. May result from damage to Wernicke's area. *Auditory hallucinations involve temporal complex. 4.Hippocampus: *Responsible for consolidating long-term memories for facts/events. *Elevated levels of cortisol appear to damage hippocampus. 5.Amygdala: *Located in temporal lobe. *Important for detecting danger, recognizing emotions, recalling emotional aspects of life events. *Consider impairment when excessive fear, emotions, and impulsivity present. 6.Parietal Lobe: *Light touch, pressure, pain, temperature vibration, propriocep- tion. *Dysfunction includes graph-motor problem (drawing clock/copying figure) and spa- tial neglect. 7.Occipital Lobe: *Visual acuity *Visual hallucinations involve the visual cortex. *Damage can cause visual problems such as difficulty recognizing objects, identify- ing colors, and recognizing words. 8.Basal Ganglia: *Important for initiation of voluntary movement. *Dysfunction can contribute to extrapyramidal symptoms. 9.Hypothalamus: *Master regulatory center. *Regulates food and fluid intake, temperature, and pituitary gland 10.Cerebellum: *Movement, balance, and posture. *Ataxia - Wide based gait. *Romberg test - difficulties maintaining balance while eyes closed. 11.Brainstem: *Midbrain, pons, medulla. 2 / *Brainstem cells produce serotonin, dopamine, norepinephrine. *Motor control, mood, memory, motivation, metabolic state *Brain injury below decussation will have effects on same side of injury. *Brain injury above decussation will have impairments on opposite side 12.Neurotransmitters: *Dopamine - Attention and executive function, motivated behaviors, addictions, mood, movement, psychosis. *Serotonin - Mood, anxiety, appetite, eating behavior, sleep. *Epinephrine - Fight or flight response *Norepinephrine - Arousal, concentration, learning and memory, mood, stress. *Acetylcholine - Arousal, cognition, memory, contraction of skeletal muscle. *Glutamate - Excitation. GABA - Inhibition. 13.Heritability of mental disorders: *Bipolar - 85-89% *Schizophrenia - 82-84% *Alcoholism - 52-58% *Anxiety Disorder - 37-43% *Major Depression - 29-42% 14.Dementias: *Alzheimer's - Related to decrease in levels of acetylcholine (ACh). *Vascular - Cognitive functioning declines in stair-step fashion after CVA. *Pick's Disease (Front-temporal impairment) - Atrophy in the frontal and temporal brain regions (neuronal loss, gliosis, masses of cytoskeletal elements) *Lewy Body - Deposition of protein in the neurons. - May have visual hallucinations *HIV/AIDS - Presentation of apathy and cognitive and motor problems. *Tertiary syphilis (Neurosyphilis) 15.Peplau: *Identified nurses' role as participant/observer *Use of self - nurses observe own behavior: strengths, weaknesses, motivations, beliefs, actions, reactions. *Professional boundaries: clarify nurses roles as separate from patients personal relationships. *Nurse avoids social, personal, financial, personal relationship with patient. *Use of self-disclosure: nurses limit sharing of personal information. - Only when brief, focused, and relevant to the goals of therapy. *Avoid giving or receiving gifts. 5 / risk factors and promoting a healthy lifestyle. 28.Secondary Prevention (Screenings): *Actions and interventions promote EARLY DIAGNOSIS of symptoms and/or timely treatment near the beginning of a disorder of disease. *Blood pressure screening, screenings for depression, alcohol abuse, screenings for cognitive ability (dementia). 29.Tertiary Prevention (Teaching r/t existing problems): *Efforts and strategies designed to MINIMIZE handicapping effects of mental disorder and problem behav- iors. *Helping patients to cope more effectively with the necessary adjustments that a serious mental health disorder imposes. *Designed to address challenging behaviors that can be dangerous or disruptive enough to impair education/job achievement/Quality of life. Example: Patient and family engagement with ACT teams. 30.Cluster A personality disorders: *Paranoid - Suspicious, mistrustful, copes by projecting attributes/shortcomings to others to justify actions. *Schizoid - Asocial pattern: aloof, introverted, seclusive, uninterested in social activ- ities, apathetic, unengaged, copes by intellectualizing. 6 / *Schizotypal - Odd, bizarre, strange, magical, eccentric, socially anxious, secretive and private, easily overwhelmed by stimulation, bizarre acts, copes by undoing. 31.Cluster B personality disorders: *Antisocial personality - Impulsive, copes by acting out, i.e. criminal/psychopath. *Borderline personality - Manipulative, demanding, "all or nothing" *Histrionic - Seductive, dramatic, sexualizes relationships, attention- seeking, ex- traverted, superficial relationships. *Narcissistic - Arrogant, entitled, egotistical, sense of superiority. 32.Cluster C personality disorders: *Avoidant - Withdrawn, sensitive to rejec- tion/humiliation, shy and uncomfortable with others, sees self as inferior, copes using fantasy/daydreams. *Dependent - Need for social approval, submissive pattern, clingy, feels inadequate, relates to others in childlike/immature way, copes using introjections (Internalizing belief of others). *Obsessive-compulsive - Meticulous, rigid, disciplined, stubborn, concerned with order and conformity, copes using reaction-formation (doing opposite of feelings). 33.Electroconvulsive Therapy (ECT): *Side effects: reversible memory loss and confusion, headache, nausea, muscle aches. - Maintain NPO status. - 100% Oxygen 5L/min until spontaneous respirations return. - Give anticholinergic drug to minimize oral and respiratory secretions. - Give muscle relaxant to minimize risk of bone fractures or injuries (Succinyl- choline). 34.Disturbances of higher level cognitive function: *Aphasia - Disruption of language function (frontal and temporal lobes). *Apraxia - Disturbance in the organization of voluntary action (e.g., putting on ones clothes). *Agnosia - Disorganization of memory processes (temporal lobe). *Amnesia - Deterioration in intellectual and cognitive function. *Alogia - Poverty of speech. 35.Anorexia: - Refusal to maintain body weight at or above 85% BMI. - Can cause cardiac arrhythmias, amenorrhea (2 missed cycles), bradycardia, tachycardia, hypotension, hypothermia, edema, skin dryness, fine downy hair. - Megace (magestrol) used to increase appetite and prevent weight loss. 36.Bulimia: - Recurrent episodes of binge eating followed by vomiting/laxative abuse. 7 / - Metabolic disturbances, electrolyte abnormalities. - Result in loss of dental enamel, esophageal tears, scars on hand. 10 / (Tofranil), and Nortriptylin (Pamelor). *Have anti-cholinergic effects *Blurred vision, drowsiness - If anti-cholinergic toxicity, physostigmine will reverse symptoms. *Can cause orthostatic Hypotension. *Monitor for ECG changes (blockage of sodium channels can cause cardiac arrhyth- mias, and CNS symptoms/vertigo/seizures. - Also check liver function tests, CBC, thyroid function. - Contraindicated for elders. *Block the absorption (reuptake) of the neurotransmitters serotonin and norepineph- rine, making more of these chemicals available in the brain. - Also block other receptors causing unwanted side effects. *Improvement in energy/sleep in 1-2 weeks, full effect 3-4 weeks. 41.Clozapine (Clozaril) (Anti-psychotic) (300-450 mg daily max. 900 mg): *Risk of developing agranulocytosis (blood disorder in which bone marrow doesn't produce enough neutrophilis) - Flu-like symptoms (High Fever, sore throat, signs of infection) *Mandatory Blood tests (WBC monitored weekly x 6 months then Q2 weeks x 6 months then Q4 weeks). Increased risk for orthostatic hypotension. *Can cause Cardiomyopathy and Myocarditis. *Can contribute to metabolic syndrome (abdominal obesity, raised blood pressure, dyslipidemia (triglycerides/cholesterol), insulin resistance, pro-inflammatory state, pro-thrombic state. *Can contribute to NEUROLEPTIC MALIGNANT SYNDROME (Life threatening). *Muscular rigidity, dystonia, akinesia, mutism, mental dullness, agitation, shaking, altered mental status. 42.Lithium (900-1800 mg/day/divided doses) (Therapeutic level 0.6-1.2 mEq/L): *Used to treat the manic episodes of Bipolar disorder (Anti-convulsant). *Lithium affects the flow of sodium through nerve and muscle cells in the body. - Sodium affects excitation or mania. *Adverse effect: Polyuria/polydipsia (monitor sodium levels) *Renal Disease may reduce renal clearance and increase serum concentration. - Check BUN/Creatinine initially and Q6 months. *Limit sun exposure (increased risk of dehydration). 11 / *Avoid NSAIDS due to decreased renal clearance. *Risk of Lithium Toxicity (>2.0 mEq/L) **Symptoms - Vomiting, Diarrhea 12 / - Course tremors, jerking of arms/legs, difficulty walking. - Slurred speech, blurred vision, marked dizziness, CONFUSION. **Treatment: Fluid replacement, dialysis, SALT THERAPY (As the serum salt level increases, the lithium level decreases), Manage blood pressure. 43.Monoamine Oxidase Inhibitors (MAOIs): *Elevate the levels of norepineph- rine, serotonin, and dopamine by inhibiting an enzyme called monoamine oxidase. *Examples include Phenelzine (Nardil), Isocarboxazid (Marplan), Tranylcypromine (Parnate), Selegiline (Zelepar, Eldepryl, Emsam). *Avoid with other antidepressants (minimum 14 days after stopping MAOI) and certain pain medications (Methadone, Tramadol, cyclobenzaprine). *May cause orthostatic hypotension. *Risk of hypertensive crisis with pseudoephedrine/St/ John's Wort. *Avoid foods containing TYRAMINE (Preserved/aged food, Red Wine, Aged Cheese, Cured/smoked meats) - Can induce HYPERTENSIVE crisis R/T excessive tyramine. - Symptoms: Severe headache, tachycardia, sweating, fever, vomiting. 44.Haldol (Antipsychotic): *Haloperidol blocks receptors for the neurotransmitters (specifically the dopamine and serotonin type 2 receptors) on the nerves. *May cause Orthostatic Hypotension. *Not approved for treatment of Dementia-related behavior problems. *Prescribed with Cogentin (Benztropine) to control for Extra-Pyramidal side effects. - Sudden, often jerky, involuntary motions of the head, neck, arms, body, or eyes. - Including tremor, slurred speech, akathisia, dystonia, anxiety, distress, paranoia, and bradyphrenia (slowed thought process) 45.Antipsychotics: *Geodon (Ziprasidone) 40-200 mg/day. - Risk of QTC prolongation (monitor ECG). *Abilify (Aripiprazole) 10-15 mg BID. - Risk of akathisia, agitation, insomnia, headache, weight gain. *Risperdal (Risperidone) 2-8 mg/day. - Increase risk of hyperprolactinemia > 6 mg/day. *Zyprexa (Olanzapine) 10-20 mg/day. - Risk of metabolic syndrome and significant weight gain. *Seroquel (Quetiapine) 150-750 mg/day.